Park Square has placed Mark Massaro as Chief Financial Officer at ArcherDX, Inc.
ArcherDX, Inc., a molecular diagnostics company developing breakthrough solutions to advance and enable the practice of personalized genomic medicine, today announced Mark Massaro has been appointed Chief Financial Officer.
https://archerdx.com/archerdx-appoints-mark-massaro-chief-financial-officer/